Book Appointment Now
OncoPanCure Launches Its Family, Friends & Fools Investment Round
OncoPanCure Therapeutics has officially launched its Family, Friends & Fools (FFF) investment round to support the next stage of preclinical development of…
OncoPanCure Announces Licensing Agreement for OPC080 with IQS School of Engineering and Xenopat
Barcelona, September 9, 2026 OncoPanCure S.L. today announced the licensing agreement with IQS School of Engineering – Universitat Ramon Llull and Xenopat…
The scientific journey behind OPC080
Years of collaborative research have laid the foundations for OncoPanCure Therapeutics While OncoPanCure Therapeutics was only recently incorporated, the scientific journey behind…
OncoPanCure Constitution (24/07/2026)
OncoPanCure SL launches to develop a first-in-class therapy for pancreatic cancer OncoPanCure Therapeutics is proud to announce its official incorporation as a…